Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000465990 | SCV000545486 | pathogenic | Charcot-Marie-Tooth disease type 4 | 2016-12-13 | criteria provided, single submitter | clinical testing | This sequence change inserts 2 nucleotide in exon 13 of the MTMR2 mRNA (c.1537_1538dupTA), causing a frameshift at codon 514. This creates a premature translational stop signal (p.Ser514Thrfs*32) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, loss-of-function variants in MTMR2 are known to be pathogenic (PMID: 10802647). For these reasons, this variant has been classified as Pathogenic. |
Knight Diagnostic Laboratories, |
RCV001270134 | SCV001449008 | pathogenic | Charcot-Marie-Tooth disease, type 4B1 | 2018-11-05 | criteria provided, single submitter | clinical testing |